Related Experiment Video
Updated: Jan 21, 2026

A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Fast and low-cost direct ELISA for high-throughput serological HPA-1a typing
Dian Winkelhorst1,2, Leendert Porcelijn3, Eva Muizelaar3
1Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands.
Insights
A new, cost-effective assay accurately identifies HPA-1a-negative women, crucial for preventing fetal and neonatal alloimmune thrombocytopenia (FNAIT). This high-throughput method enables widespread screening for FNAIT, improving maternal and infant health outcomes.
Area of Science:
- Immunology
- Genetics
- Obstetrics
Background:
- Fetal and neonatal alloimmune thrombocytopenia (FNAIT) results from maternal antibodies against fetal human platelet antigens (HPAs), primarily anti-HPA-1a.
- Population-based screening for FNAIT is debated due to the logistical and financial challenges of HPA-1a typing in pregnant women.
- A need exists for a high-throughput, low-cost assay for HPA-1a typing to facilitate screening.
Purpose of the Study:
- To develop and validate a high-throughput, low-cost HPA-1a phenotyping assay.
- To assess the assay's reliability for population-based screening of pregnant women.
- To enable efficient identification of HPA-1a-negative women for FNAIT risk assessment.
Main Methods:
- A sandwich ELISA was developed using anti-GPIIIa coating and HRP-conjugated anti-HPA-1a detecting antibodies.
- Assay performance was compared against an allelic discrimination PCR assay.
- Two phases of testing were conducted: Phase I with 506 unselected pregnant women and Phase II with 62,171 samples, including supportive genotyping.
Main Results:
- The ELISA assay demonstrated 100% sensitivity with a cut-off OD of 0.160.
- Specificity was determined to be 99.9%, with a false-HPA-1a negative rate of 0.03%.
- The assay is optimized for stored plasma samples, usable from 3- to 6-day-old samples.
Conclusions:
- A high-throughput, low-cost, and reliable HPA-1a phenotyping assay has been successfully developed.
- This assay is suitable for population-based screening to identify women requiring anti-HPA-1a testing.
- The assay's applicability in suboptimal conditions makes it valuable for widespread FNAIT screening.
Background:
Fetal and neonatal alloimmune thrombocytopenia (FNAIT) is caused by maternal alloantibodies against fetal human platelet antigens (HPAs), mostly caused by anti-HPA-1a. Population-based screening for FNAIT is still a topic of debate. Logistically and financially, the major challenge for implementation is the typing of pregnant women to recognize the 2% HPA-1a-negative women. Therefore, there is need for a high-throughput and low-cost HPA-1a-typing assay.
Study Design And Methods:
A sandwich ELISA was developed, using a monoclonal anti-GPIIIa as coating antibody and horseradish-peroxidase-conjugated recombinant anti-HPA-1a, as detecting antibody. The ELISA results were compared to an allelic discrimination PCR-assay. In phase I, samples from unselected consecutive pregnant women were tested with both assays. Phase II was part of a prospective screening study in pregnancy and genotyping was restricted to samples with an arbitrary set, OD < 0.500.
Results:
The ELISA was optimized to require no additional handling (swirling or spinning) of stored tubes. During phase I, 506 samples were tested. In phase II, another 62,171 consecutive samples were phenotyped, with supportive genotyping in 1,902. In total 1,585 HPA-1a negative and 823 HPA-1a positive women were genotyped. The assay reached 100% sensitivity with a cut-off OD from 0.160, corresponding with a 99.9% specificity and a false-HPA-1a negative rate of 0.03.
Conclusion:
A high-throughput, low-cost, and reliable HPA-1a phenotyping assay was developed which can be used in population-based screening to select samples for testing of presence of anti-HPA-1a. Because plasma from tubes of 3- to 6-days-old samples can be used, this assay is applicable to settings with suboptimal conditions.
More Related Videos
08:523D Ultrasound Imaging: Fast and Cost-effective Morphometry of Musculoskeletal Tissue
Published on: November 27, 2017
08:22Retroviral Overexpression of CXCR4 on Murine B-1a Cells and Adoptive Transfer for Targeted B-1a Cell Migration to the Bone Marrow and IgM Production
Published on: May 31, 2020
Related Concept Videos
Fast Fourier Transform
The computational efficiency of the FFT becomes...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Directing Effect of Substituents: meta-Directing Groups
Gene Evolution - Fast or Slow?
In contrast, regions which code...
Gene Evolution - Fast or Slow?
Fast Decoupled and DC Powerflow